Advocate Christ Medical Center Extends Leadership in Heart Care with Adoption of Genesis Robotic Technology
May 23, 2023 08:46 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 23, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the first treatment of...
Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms
May 19, 2023 08:38 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’...
Stereotaxis Reports 2023 First Quarter Financial Results
May 09, 2023 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis to Report First Quarter 2023 Financial Results on May 9, 2023
April 18, 2023 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
Over 1,000 Cardiac Patients Treated with Genesis Robotic System
April 13, 2023 09:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 13, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that over...
Broward Health Medical Center the First Hospital in Florida Using Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders
March 20, 2023 08:08 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the grand...
Stereotaxis Reports 2022 Full Year Financial Results
March 03, 2023 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 03, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis to Present at Cowen 43rd Annual Health Care Conference
February 21, 2023 09:03 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
Stereotaxis to Report Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023
February 02, 2023 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System
December 20, 2022 09:04 ET
|
Stereotaxis, Inc.
ST. LOUIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of...